Will Merck Stock Rise After Its Q3 Results? 0 25.10.2022 15:00 Forbes.com Merck’s top-selling drug - Keytruda - saw its sales rise 26% to $5.3 billion in Q2, while Gardasil sales were up a significant 36% to $1.7 billion. Партнёры Smi24.net Все новости за 24 часа Музыкальные новости Агрегатор новостей 24СМИ
